. (2012). Incidence of genital infection among patients with type 2 diabetes in the UK General Practice Research Database. J Diabetes Complications. http://doi.org/10.1016/j.jdiacomp.2012.06.012
N. Hammar
First name
N.
Last name
Hammar
. (2012). Incidence of urinary tract infection among patients with type 2 diabetes in the UK General Practice Research Database (GPRD). J Diabetes Complications. http://doi.org/10.1016/j.jdiacomp.2012.06.008
. (2016). Weight change and healthcare resource use in English patients with type 2 diabetes mellitus initiating a new diabetes medication class. Int J Clin Pract. http://doi.org/10.1111/ijcp.12746
. (2017). Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotranspo. Circulation. http://doi.org/10.1161/circulationaha.117.029190
. (2017). Changes in HbA1c and weight after initiation of second-line therapy in patients with type 2 diabetes in clinical practice. Diabetologia.
. (2018). SGLT-2 Inhibitors and Cardiovascular Risk: An Analysis of CVD-REAL. J Am Coll Cardiol. http://doi.org/10.1016/j.jacc.2018.01.085
. (2018). Changes in HbA1c and weight, and treatment persistence, over the 18 months following initiation of second-line therapy in patients with type 2 diabetes: results from the United Kingdom Clinical Practice Research Datalink. BMC Med. http://doi.org/10.1186/s12916-018-1085-8